EZH2 and lung carcinoma: However, YAP/TAZ makes a contribution to promoting the evolution of lung cancer through decreasing the expression of TGFBR2 and YAP/TAZ and enhancer of zeste homolog 2 (EZH2) have a synergistic effect in this process.172